Does prior treatment with fumaric acid esters predispose to tuberculosis in patients on etanercept?
Ahmad
K
K
McDonnell
T J
TJ
Rogers
S
S
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D004198:Disease Susceptibility; D004338:Drug Combinations; D000068800:Etanercept; D005650:Fumarates / Q000009:adverse effects*; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008297:Male; D011565:Psoriasis / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor; D016896:Treatment Outcome; D014374:Tuberculin Test; D014388:Tuberculosis, Lymph Node / Q000139:chemically induced*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D005650:Fumarates; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept